Adjuvant systems

Our adjuvant technologies not only advance the results of allergy immunotherapy but also drive beneficial immune responses in cancer and infectious disease. They improve therapies by allowing them to act faster and we now help others by using this knowledge; improving health and developing vaccinations for infectious disease and cancer treatments.

Through our Bencard Adjuvant Systems division we are engaging in long-term partnerships with those who require our patented platform of adjuvant technologies to enable successful vaccine or immunotherapy development.

Our Adjuvant Systems